Aclaris Therapeutics

Filed a patent for "crystalline polymorph form a of a jak inhibitor and methods for its preparation" on Wed, August 16, 2023

Filed a patent for "methods and compositionsfor treating viral infections" on Thu, May 18, 2023

Filed a patent for "process, compositions, and crystalline forms of substituted pyridinone-pyridinyl compounds" on Thu, August 3, 2023

Filed a patent for "pyrrolopyrimidine compositions for treatment of itk mediated conditions" on Tue, November 8, 2022

Filed a patent for "methods of synthesizing deuterated substituted pyridinone-pyridinyl compounds" on Thu, September 14, 2023

Filed a patent for "crystalline polymorph form a of a jak inhibitorand methods for its preparation" on Thu, November 16, 2023

Filed a patent for "substituted pyrrolopyridine jak inhibitors and methods of making and using the same" on Thu, February 29, 2024

Filed a patent for "methods of synthesizing substituted pyridinone-pyridinyl compounds" on Thu, February 8, 2024

Filed a patent for "topical formulations of a jak 1/3 inhibitor and methods of use thereof for treatment of atopic dermatitis and other skin conditions" on Thu, May 2, 2024

Filed a patent for "pyrrolopyrimidine compositions for treatment of itk mediated conditions" on Mon, September 18, 2023

Filed a patent for "pyrrolopyrimidine itk inhibitors" on Thu, April 25, 2024

Filed a patent for "oral compositions of mk2 pathway inhibitor for treatment of immune conditions" on Thu, June 20, 2024

Filed a patent for "substituted pyrrolopyridines as jak inhibitors" on Thu, November 24, 2022